Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$18M Buy
106,081
+27,027
+34% +$5.06M 0.68% 45
2023
Q4
$15.6M Buy
79,054
+7,772
+11% +$1.38M 0.65% 54
2023
Q3
$12.4M Buy
71,282
+69,880
+4,984% +$12.7M 0.57% 60
2023
Q2
$241K Buy
1,402
+102
+8% +$17.6K 0.01% 254
2023
Q1
$216K Buy
1,300
+27
+2% +$4.42K 0.01% 267
2022
Q4
$187K Buy
1,273
+286
+29% +$42.3K 0.01% 296
2022
Q3
$147K Sell
987
-50
-5% -$8.36K 0.01% 317
2022
Q2
$178K Buy
1,037
+212
+26% +$36.7K 0.01% 311
2022
Q1
$156K Buy
825
+176
+27% +$34.8K 0.01% 365
2021
Q4
$158K Buy
+649
New +$142K 0.01% 361
2020
Q4
Sell
-1,660
Closed -$275K 245
2020
Q3
$275K Hold
1,660
0.01% 197
2020
Q2
$258K Sell
1,660
-105
-6% -$13.7K 0.01% 209
2020
Q1
$208K Hold
1,765
0.01% 219
2019
Q4
$234K Sell
1,765
-10
-0.6% -$1.24K 0.01% 250
2019
Q3
$221K Buy
+1,775
New +$214K 0.01% 246

Other funds holding ZTS

Cambridge Trust's ZTS Position: Q1 2024 in Review

Cambridge Trust increased its Zoetis (ZTS) stake by 34% in Q1 2024, buying an estimated $5.06M and bringing the position to 106,081 shares worth $18M. The position accounts for 0.68% of the portfolio, ranked #45.

Cambridge Trust first reported a position in ZTS in Q3 2019 and has held it in 15 quarters since. 1,736 funds tracked by Wall St. Rank hold ZTS as of Q1 2024.

  • Cambridge Trust held 106,081 shares of Zoetis worth $18M as of Q1 2024.
  • Cambridge Trust bought 27,027 Zoetis shares in Q1 2024, an estimated $5.06M.
  • Zoetis made up 0.68% of Cambridge Trust's portfolio in Q1 2024, its #45 holding.
  • Cambridge Trust first reported a position in Zoetis in Q3 2019 and has held it in 15 quarters since.
  • 1,736 funds tracked by Wall St. Rank held Zoetis as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.